DRUG · Unmapped registry intervention
Nuvastatic 300
Find medicine records ·
Find other trials using this name
Clinical trial
Nuvastatic® Phase III Trial for Fatigue in Triple-Negative Breast Cancer
NCT07669467
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedNuvastatic® Phase III Trial for Fatigue in Triple-Negative Breast Cancer
Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Fatigue Related to Cancer Treatmentunresolved
Breast Cancerverified · MONDO: breast cancer
Interventions
Nuvastatic 300DRUG
PlaceboDRUG
Sponsors & collaborators
Natureceuticals Sdn Bhdlead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07669467 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.